Zobrazeno 1 - 10
of 163
pro vyhledávání: '"T. Umiel"'
Autor:
D. Lamontagne, David Avigan, N. Giallombardo, David F. McDermott, Robin Joyce, Thomas J. Smith, Meredith M. Regan, J. Ottaway, Lynne Uhl, T. Umiel, James D. Levine, D. Hurley, J.-C. Tetreault
Publikováno v:
Annals of Oncology. 14:i21-i27
This phase I–II study describes the safety of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) as an induction regimen prior to high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), and rituximab given post-HDC-ASCT f
Autor:
T Umiel, Elena Elstner, Jonathan W. Said, H P Koeffler, P Michl, J Le, L. Binderup, J C Reed, Mariana Linker-Israeli
Publikováno v:
Journal of Clinical Investigation. 99:349-360
Patients with acute promyelocytic leukemia (APL) usually relapse after all-trans retinoic acid (RA) treatment because this therapy fails to eradicate the malignant clone. Our data showed that KH 1060 and other 20-epi vitamin D3 analogs alone were pot
Publikováno v:
Blood. 82:1829-1837
We report the establishment of a novel cell line from a pediatric patient with recurrent non-Hodgkin's lymphoma. This cell line, termed USP-91, showed both T-lymphoid cell as well as myeloid (ie, nonlymphoid) cell characteristics using a comprehensiv
Publikováno v:
Clinica chimica acta
Human white blood cells were shown to contain high aminopeptidase P activity. The specific activities found in the high-speed supernatant of the extracts of granulocytes, lymphocytes and monocytes ranged from 30 to 70 units per mg protein. Culturing
Autor:
M. Prilutskaya, T.J. Moss, S. Yanovich, E.L. Snyder, Diane S. Krause, B Mills, M. Griffith, T. Umiel, V. Mansour, J. Burgess, C.H. Weaver, L.S. Schwartzberg
Publikováno v:
Cytotherapy. 3(4)
Background Positive selection of CD34 + cells may reduce or eliminate tumor cells contaminating PBSC harvests of breast cancer (BrCa) patients. However, to assess tumor purging accurately methods may be needed that are of higher sensitivity than stan
Autor:
R M, Joyce, C N, Kraser, J C, Tetrealt, N, Giallombardo, D, McDermott, J, Levine, T, Umiel, M, Regan, D, Hurley, L, Uhl, D, Avigan
Publikováno v:
European journal of haematology. Supplementum. 64
A phase I/II study was performed to analyse the ability of ifosfamide-based chemotherapy with rituximab to produce a turmour-free graft as well as the safety of retuximab prior to stem cell harvest and post high-dose chemotherapy. Twenty-two patients
Publikováno v:
Scopus-Elsevier
The human TALL-104 cell line possesses major histocompatibility complex non-restricted cytotoxic activity against a large variety of tumor targets. Adequate therapies for prostate cancer that has spread outside its capsule are lacking. In order to id
Publikováno v:
Leukemia. 11(3)
All-trans retinoic acid (RA) induces granulocytic differentiation of acute promyelocytic leukemia cells both in vivo and in vitro. In the HL-60 wild-type (WT) early promyelocytic leukemia cell line, granulocytic differentiation appears to be directly
Publikováno v:
Acute Leukemias VI ISBN: 9783642643798
All-trans retinoic acid (RA) is the first highly effective differentiation-inducing agent for remission induction in patients with APL, but remissions are short-lived because the treatment fails to eliminate the malignant clone and clinical resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf1d3b6a17c3d02b5cf6c95d6361b40
https://doi.org/10.1007/978-3-642-60377-8_35
https://doi.org/10.1007/978-3-642-60377-8_35
Autor:
E, Elstner, M, Linker-Israeli, T, Umiel, J, Le, I, Grillier, J, Said, I P, Shintaku, S, Krajewski, J C, Reed, L, Binderup, H P, Koeffler
Publikováno v:
Cancer research. 56(15)
All-trans retinoic acid (RA) is the first highly effective differentiation-inducing agent for remission induction in patients with acute promyelocytic leukemia. However, remissions are short-lived because the treatment fails to induce complete differ